Treatment of neuropathic corneal pain with ngf
Номер патента: EP4322987A1
Опубликовано: 21-02-2024
Автор(ы): Flavio MANTELLI, Pedram Hamrah
Принадлежит: Dompe Farmaceutici SpA, Tufts Medical Center Inc
Опубликовано: 21-02-2024
Автор(ы): Flavio MANTELLI, Pedram Hamrah
Принадлежит: Dompe Farmaceutici SpA, Tufts Medical Center Inc
Реферат: The present invention relates to methods of treating neuropathic corneal pain (NCP) comprising administration of nerve growth factor (NGF).
Treatment of neuropathic corneal pain with ngf
Номер патента: US20240197829A1. Автор: Pedram Hamrah,Flavio MANTELLI. Владелец: Dompe Farmaceutici SpA. Дата публикации: 2024-06-20.